← ANALYSTS · TIPRANKS
Gena Wang · Barclays
Hits
44%
207 of 474 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+2.4%
Over a year after the rating, TipRanks’ measure
Our companies rated now
8
Buy / hold / sell: 2 / 5 / 1
Upside of the analyst’s targets
−3.5%
Average over 8 current targets, to the last price
The market’s answer to the ratings
+11.0%
Day-0 move against SPY in the rating’s direction, average over 3 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Nov 17on TipRanks 04:55 | KODIWMKodiak Sciences · $5.5B | Reiterated | Hold | $17.00 | −80.2% | +2.6%next day −2.2% · 5 days +9.8% | ↗ |
| Nov 11on TipRanks 04:00 | EDITIWMEditas Medicine · $375M | Reiterated | Hold | $3.00 | +27.7% | +5.3%next day +1.4% · 5 days +1.9% | ↗ |
| Nov 11on TipRanks 04:00 | CRSPIWMCrispr Therapeutics AG · $5.0B | Reiterated | Hold | $56.00 | +13.7% | +0.9%next day −5.5% · 5 days +0.2% | ↗ |
| Nov 7on TipRanks 07:55 | PBYIIWMPuma Biotechnology · $527M | Reiterated | Sell | $2.00 | −79.7% | +22.1%next day −22.6% · 5 days −18.5% | ↗ |
| Nov 7on TipRanks 05:15 | NTLAIWMIntellia Therapeutics · $1.6B | Reiterated | Buy | $24.00 → $14.00−41.7% | +22.6% | −22.8%next day +0.6% · 5 days −8.8% | ↗ |
| Nov 5on TipRanks 03:50 | BEAMIWMBeam Therapeutics · $2.6B | Reiterated | Hold | $21.00 | −10.5% | +1.1%next day +1.4% · 5 days −6.1% | ↗ |
| Nov 3on TipRanks Nov 4 03:20 | BCRXIWMBioCryst · $2.0B | Reiterated | Hold | $11.00 → $9.00−18.2% | +15.5% | −6.5%next day −0.3% · 5 days +5.2% | ↗ |
| Nov 3on TipRanks Nov 4 03:20 | SLDBIWMSolid Biosciences · $615M | Reiterated | Buy | $10.00 → $9.00−10.0% | +62.7% | −3.7%next day −14.2% · 5 days −19.9% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗